Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11926817rdf:typepubmed:Citationlld:pubmed
pubmed-article:11926817lifeskim:mentionsumls-concept:C0248266lld:lifeskim
pubmed-article:11926817lifeskim:mentionsumls-concept:C0521119lld:lifeskim
pubmed-article:11926817lifeskim:mentionsumls-concept:C0596788lld:lifeskim
pubmed-article:11926817pubmed:issue14lld:pubmed
pubmed-article:11926817pubmed:dateCreated2002-4-2lld:pubmed
pubmed-article:11926817pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11926817pubmed:abstractTextThe structure of the third extracellular loop of the human cholecystokinin-2 receptor, CCK2-R(352-379), and its interactions with the C-terminal octapeptide of cholecystokinin (CCK-8) have been determined by high-resolution NMR and computer simulations. In the presence of dodecylphosphocholine micelles, the structure of the receptor fragment consisted of three helices, with the first and third corresponding to residues of the extracellular ends of transmembrane helices (TM) 6 and 7, respectively. The central, extracellular helix, consisting of residues 363-368, was found to be closely associated with the membrane mimetic used during the spectroscopic studies and molecular dynamics (MD) simulations. Upon titration of CCK-8 to the receptor domain, chemical shift perturbation and intermolecular NOEs (Trp30, Met31 of CCK-8 and P371, F374 of CCK2-R) indicated the formation of a stable complex and specific ligand/receptor interactions. Using the NOE-generated intermolecular contact points, extensive MD simulations of CCK-8 bound to the CCK2 receptor were carried out. The results, with CCK-8 in close proximity to TM7, differ from previous structural studies of CCK-8 association with CCK1-R, in which the ligand formed a number of interactions with TM6. These differences may play a role in the ligand specificity displayed by the CCK1 and CCK2 receptor subtypes.lld:pubmed
pubmed-article:11926817pubmed:languageenglld:pubmed
pubmed-article:11926817pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11926817pubmed:citationSubsetIMlld:pubmed
pubmed-article:11926817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11926817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11926817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11926817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11926817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11926817pubmed:statusMEDLINElld:pubmed
pubmed-article:11926817pubmed:monthAprlld:pubmed
pubmed-article:11926817pubmed:issn0006-2960lld:pubmed
pubmed-article:11926817pubmed:authorpubmed-author:MierkeDale...lld:pubmed
pubmed-article:11926817pubmed:authorpubmed-author:GiragossianCr...lld:pubmed
pubmed-article:11926817pubmed:issnTypePrintlld:pubmed
pubmed-article:11926817pubmed:day9lld:pubmed
pubmed-article:11926817pubmed:volume41lld:pubmed
pubmed-article:11926817pubmed:ownerNLMlld:pubmed
pubmed-article:11926817pubmed:authorsCompleteYlld:pubmed
pubmed-article:11926817pubmed:pagination4560-6lld:pubmed
pubmed-article:11926817pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:meshHeadingpubmed-meshheading:11926817...lld:pubmed
pubmed-article:11926817pubmed:year2002lld:pubmed
pubmed-article:11926817pubmed:articleTitleIntermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin-2 receptor.lld:pubmed
pubmed-article:11926817pubmed:affiliationDepartment of Chemistry, Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912, USA.lld:pubmed
pubmed-article:11926817pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11926817pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:887entrezgene:pubmedpubmed-article:11926817lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11926817lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11926817lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11926817lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11926817lld:pubmed